Figure 1
From: Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?
Measurements of whole body (A), lumbar spine (B) and femoral neck (C) bone mineral content (BMC) (kg) as well as whole body (D), lumbar spine (E) and femoral neck (F) bone mineral density (BMD) (g/cm2) in female normal controls, patients with Hashimoto's thyroiditis and premenopausal women with Graves' diseases during 36 ± 3 months follow-up (at baseline, 3 and 18 ± 3 months on antithyroid drug therapy and additional 18 ± 3 months without antithyroid drug thyroid therapy or to relapse). + Represents back transformed mean. Significant differences to baseline (B) or to control group (N): * = p < 0.05 and ns = non significant.